Post SELECT: Selenium on Trial

• Thomson CD . Assessment of requirements for selenium and adequacy of selenium status: a review.Eur. J. Clinical Nutr.58(3), 391–402 (2004).
   PubMed Web of Science ®Google Scholar
• Goldhaber SB . Trace element risk assessment: essentiality vs. toxicity.Regul. Toxicol. Pharmacol.38(2), 232–242 (2003).
   PubMed Web of Science ®Google Scholar
• Spallholz JE , BoylanLM, LarsenHS. Advances in understanding selenium’s role in the immune system.Ann. NY Acad. Sci.587, 123–139 (1990).
   PubMed Web of Science ®Google Scholar
• Taylor EW , NadimpalliRG, RamanathanCS. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins.Biol. Trace Elem. Res.56(1), 63–91 (1997).
   PubMed Web of Science ®Google Scholar
• Hawkes WC , HornbostelL. Effects of dietary selenium on mood in healthy men living in a metabolic research unit.Biol. Psychiatry39(2), 121–128 (1996).
   PubMed Web of Science ®Google Scholar
• Benton D , CookR. The impact of selenium supplementation on mood.Biol. Psychiatry29(11), 1092–1098 (1991).
   PubMed Web of Science ®Google Scholar
• Sher L . Depression and suicidal behavior in alcohol abusing adolescents: possible role of selenium deficiency.Minerva Pediatr.60(2), 201–209 (2008).
   PubMedGoogle Scholar
• Benton D . Selenium intake, mood and other aspects of psychological functioning.Nutr. Neurosci.5(6), 363–374 (2002).
   PubMed Web of Science ®Google Scholar
• Mistry HD , Broughton Pipkin FB, Redman CW, Poston L. Selenium in reproductive health. Am. J. Obstet. Gynecol.206(1), 21–30 (2012).
   PubMedGoogle Scholar
• Vanderpas JB , ContempreB, DualeNLet al. Iodine and selenium deficiency associated with cretinism in northern Zaire. Am. J. Clin. Nutr. 52(6), 1087–1093 (1990).
   PubMed Web of Science ®Google Scholar
• Knekt P , HeliövaaraM, AhoK, AlfthanG, MarniemiJ, AromaaA. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis.Epidemiology11(4), 402–405 (2000).
   PubMed Web of Science ®Google Scholar
• McCloy R . Chronic pancreatitis at Manchester, UK. Focus on antioxidant therapy.Digestion59(Suppl. 4), 36–48 (1998).
   PubMedGoogle Scholar
• Flatt A , PearceN, ThomsonCD, SearsMR, RobinsonMF, BeasleyR. Reduced selenium in asthmatic subjects in New Zealand.Thorax45(2), 95–99 (1990).
   PubMed Web of Science ®Google Scholar
• Reid ME , Duffield-LillicoAJ, GarlandL, TurnbullBW, ClarkLC, MarshallJR. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.Cancer Epidemiol. Biomarkers Prev.11(11), 1285–1291 (2002).
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K . The role of selenium in cancer prevention. In: Cancer Principles and Practice of Oncology (4th). J.B. Lippincott, PA, USA, 1–15 (1991).
   Google Scholar
• Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol. Ther.79(3), 179–192 (1998).
   PubMed Web of Science ®Google Scholar
• Combs GF Jr, Lu J. Selenium as a cancer preventive agent. In: Selenium: Its Molecular Biology and Role in Human Health. Hatfield DL (Ed.). Springer, NY, USA, 205–218 (2001).
   Google Scholar
• Reinhold U , BiltzH, BayerW, SchmidtKH. Serum selenium levels in patients with malignant melanoma.Acta. Derm. Venereol.69(2), 132–136 (1989).
   PubMed Web of Science ®Google Scholar
• Mikac-Devic M , VukelicN, KljaicK. Serum selenium level in patients with colorectal cancer.Biol. Trace Elem. Res.33, 87–94 (1992).
   PubMed Web of Science ®Google Scholar
• Milde D , NovakO, Stu ka V, Vyslou il K, Macha ek J. Serum levels of selenium, manganese, copper, and iron in colorectal cancer patients. Biol. Trace Elem. Res.79(2), 107–114 (2001).
   PubMed Web of Science ®Google Scholar
• Sancak B , ÜnalA, CandanS, CokunU, GünelN. Association between oxidative stress and selenium levels in patients with breast cancer at different clinical stages.J. Trace Elem. Exp. Med.16, 87–94 (2003).
   Google Scholar
• McConnell KP , JagerRM, BlandKI, BlotckyAJ. The relationship of dietary selenium and breast cancer.J. Surg. Oncol.15(1), 67–70 (1980).
   PubMed Web of Science ®Google Scholar
• Schrauzer GN , MolenaarT, MeadS, KuehnK, YamamotoH, ArakiE. Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease.Jpn. J. Cancer Res.76(5), 374–377 (1985).
   PubMedGoogle Scholar
• Krsnjavi H , BekerD. Serum selenium level as a diagnostic parameter in breast cancer.Helv. Chir. Acta.59(1), 231–234 (1992).
   PubMedGoogle Scholar
• Lopez-Saez JB , Senra-VarelaA, Pousa-EstevezL. Selenium in breast cancer.Oncology64(3), 227–231 (2003).
   PubMed Web of Science ®Google Scholar
• Sundstrom H , YrjanheikkiE, KauppilaA. Serum selenium in patients with ovarian cancer during and after therapy.Carcinogenesis5(6), 731–734 (1984).
   PubMed Web of Science ®Google Scholar
• Pourmand G , SalemS, MoradiK, NikoobakhtMR, TajikP, MehrsaiA. Serum selenium level and prostate cancer: a case-control study.Nutr. Cancer60(2), 171–176 (2008).
   PubMed Web of Science ®Google Scholar
• Yadav SP , GeraA, SinghI, ChandaR. Serum selenium levels in patients with head and neck cancer.J. Otolaryngol.31(4), 216–219 (2002).
   PubMedGoogle Scholar
• Rayman MP . Selenium in cancer prevention: a review of the evidence and mechanism of action.Proc. Nutr. Soc.64(4), 527–542 (2005).
   PubMed Web of Science ®Google Scholar
• Ip C . Lessons from basic research in selenium and cancer prevention.J. Nutr.128(11), 1845–1854 (1998).
   PubMed Web of Science ®Google Scholar
• Zeng H , CombsGF Jr. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J. Nutr. Biochem.19(1), 1–7 (2008).
   PubMed Web of Science ®Google Scholar
• Brown KM , ArthurJR. Selenium, selenoproteins and human health: a review.Public Health Nutr.4(2B), 593–599 (2001).
   PubMedGoogle Scholar
• Facompre N , El-BayoumyK. Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.Cancer Res.69(7), 2699–2703 (2009).
   PubMed Web of Science ®Google Scholar
• Sanmartin C , PlanoD, FontM, PalopJA. Selenium and clinical trials: new therapeutic evidence for multiple diseases.Curr. Med. Chem.18(30), 4635–4650 (2011).
   PubMed Web of Science ®Google Scholar
• Sanmartin C , PlanoD, FontM, PalopJA. Kinase regulation by sulfur and selenium containing compounds.Curr. Cancer Drug Targets11(4), 496–523 (2011).
   PubMed Web of Science ®Google Scholar
• Marshall JR . Larry Clark’s legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.Nutr. Cancer40(1), 74–77 (2001).
   PubMed Web of Science ®Google Scholar
• Mugesh G , Du Mont WW, Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev.101(7), 2125–2179 (2001).
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe R . Selenium compounds and selenoproteins in cancer.Chem. Biodivers.5(3), 389–395 (2008).
   PubMed Web of Science ®Google Scholar
• Drake EN . Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.Med. Hypotheses67(2), 318–322 (2006).
   PubMed Web of Science ®Google Scholar
• Sinha R , El-BayoumyK. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds.Curr. Cancer Drug Targets4(1), 13–28 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao R , DomannFE, ZhongW. Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells.Mol. Cancer Ther.5(12), 3275–3284 (2006).
   PubMed Web of Science ®Google Scholar
• Novoselov SV , CalvisiDF, LabunskyyVMet al. Selenoprotein deficiency and high levels of selenium compounds can effectively inhibit hepatocarcinogenesis in transgenic mice. Oncogene 24(54), 8003–8011 (2005).
   PubMed Web of Science ®Google Scholar
• Sanmartin C , PlanoD, SharmaAK, PalopJA. Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy.Int. J. Mol. Sci.13, 9649–9672 (2012).
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K . Overview: the late Larry C. Clark showed the bright side of the moon element (selenium) in a clinical cancer prevention trial.Nutr. Cancer40(1), 4–5 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma A , SharmaAK, MadhunapantulaSVet al. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clin. Cancer Res. 15(5), 1674–1685 (2009).
   PubMed Web of Science ®Google Scholar
• Sharma AK , SharmaA, DesaiDet al. Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. J. Med. Chem. 51(24), 7820–7826 (2008).
   PubMed Web of Science ®Google Scholar
• Sharma AK , KlineCL, BergA, AminS, IrbyRB. The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.Clin. Cancer Res.17(13), 4474–4483 (2011).
   PubMed Web of Science ®Google Scholar
• Madhunapantula SV , DesaiD, SharmaA, HuhSJ, AminS, RobertsonGP. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.Mol. Cancer Ther.7(5), 1297–1308 (2008).
   PubMed Web of Science ®Google Scholar
• Cheng Y , SkUH, ZhangYet al. Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death. PLoS ONE 7(4), e35104 (2012).
   PubMed Web of Science ®Google Scholar
• Clark LC , DalkinB, KrongradAet al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol. 81(5), 730–734 (1998).
   PubMedGoogle Scholar
• Lippman SM , KleinEA, GoodmanPJet al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1), 39–51 (2009).
   PubMed Web of Science ®Google Scholar
• Ledesma MC , Jung-HynesB, SchmitTL, KumarR, MukhtarH, AhmadN. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.Mol. Med .17(1–2), 134–143 (2011).
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K , SinhaR. Molecular chemoprevention by selenium: a genomic approach.Mutat. Res.591(1–2), 224–236 (2005).
   PubMed Web of Science ®Google Scholar
• Yan L , DemarsLC. Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.Int. J. Cancer131(6), 1260–1266 (2012).
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K , RichieJP Jr, Boyiri T et al. Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiol. Biomarkers Prev.11(11), 1459–1465 (2002).
   PubMed Web of Science ®Google Scholar
• Micke O , SchomburgL, BuentzelJ, KistersK, MueckeR. Selenium in oncology: from chemistry to clinics.Molecules14(10), 3975–3988 (2009).
   PubMed Web of Science ®Google Scholar
• Dunn BK , RichmondES, MinasianLM, RyanAM, FordLG. A nutrient approach to prostate cancer prevention: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).Nutr. Cancer62(7), 896–918 (2010).
   PubMed Web of Science ®Google Scholar
• El-Bayoumy K . The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis.Nutr. Cancer61(3), 285–286 (2009).
   PubMed Web of Science ®Google Scholar
• Costello AJ . A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: rationale, recruitment, and design issues.Urology57(4 Suppl. 1), 182–184 (2001).
   PubMedGoogle Scholar
• Duffield-Lillico AJ , DalkinBL, ReidMEet al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int. 91(7), 608–612 (2003).
   PubMed Web of Science ®Google Scholar
• Novotny L , RaukoP, KombianSB, EdafioghoIO. Selenium as a chemoprotective anti-cancer agent: reality or wishful thinking?Neoplasma57(5), 383–391 (2010).
   PubMed Web of Science ®Google Scholar
• Dennert G , ZwahlenM, BrinkmanM, VincetiM, ZeegersMP, HorneberM. Selenium for preventing cancer.Cochrane Database Syst. Rev. (5), CD005195 (2011).
   PubMed Web of Science ®Google Scholar
• Männistö S , AlfthanG, VirtanenM, KatajaV, UusitupaM, PietinenP. Toenail selenium and breast cancer-a case-control study in Finland.Eur. J.Clin. Nutr.54(2), 98–103 (2000).
   PubMed Web of Science ®Google Scholar
• Brozmanova J , ManikovaD, VlckovaV, ChovanecM. Selenium: a double-edged sword for defense and offence in cancer.Arch. Toxicol.84(12), 919–938 (2010).
   PubMed Web of Science ®Google Scholar
• Muecke R , SchomburgL, BuentzelJ, KistersK, MickeO. Selenium or no selenium–that is the question in tumor patients: a new controversy.Integr. Cancer Ther.9(2), 136–141 (2010).
   PubMed Web of Science ®Google Scholar
• Ibanez E , PlanoD, FontMet al. Synthesis and antiproliferative activity of novel symmetrical alkylthio- and alkylseleno-imidocarbamates. Eur. J. Med. Chem. 46(1), 265–274 (2011).
   PubMed Web of Science ®Google Scholar
• Moreno E , PlanoD, LambertoIet al. Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitro. Eur. J. Med. Chem. 47(1), 283–298 (2012).
   PubMedGoogle Scholar
• Plano D , BaquedanoY, Moreno-MateosDet al. Selenocyanates and diselenides: a new class of potent antileishmanial agents. Eur. J. Med. Chem. 46(8), 3315–3323 (2011).
   PubMed Web of Science ®Google Scholar
• Plano D , IbanezE, CalvoA, PalopJA, SanmartinC. Novel library of selenocompounds as kinase modulators.Molecules16(8), 6349–6364 (2011).
   PubMed Web of Science ®Google Scholar
• Roy SS , GhoshP, SkUHet al. Naphthalimide based novel organoselenocyanates: finding less toxic forms of selenium that would retain protective efficacy. Bioorg. Med. Chem. Lett. 20(23), 6951–6955 (2010).
   PubMed Web of Science ®Google Scholar
• Sharma AK , SkUH, HeP, PetersJM, AminS. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.Bioorg. Med. Chem. Lett.20(14), 4050–4052 (2010).
   PubMed Web of Science ®Google Scholar
• Nguyen N , SharmaA, SharmaAKet al. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prev. Res. (Phila.) 4(2), 248–258 (2011).
   PubMed Web of Science ®Google Scholar
• Sk UH , SharmaAK, GhoshS, BhattacharyaS. Synthesis and biological evaluation of novel spiro 6-methoxytetralin-1,3´-pyrrolidine based organoselenocyanates against cadmium-induced oxidative and hepatic damage in mice.Eur. J. Med. Chem.45(8), 3265–3273 (2010).
   PubMed Web of Science ®Google Scholar
• Ip C , GantherHE. Comparison of selenium and sulfur analogs in cancer prevention.Carcinogenesis13(7), 1167–1170 (1992).
   PubMed Web of Science ®Google Scholar
• Huber RE , CriddleRS. Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs.Arch. Biochem. Biophys.122(1), 164–173 (1967).
   PubMed Web of Science ®Google Scholar
• Jacob C , GilesGI, GilesNM, SiesH. Sulfur and selenium: the role of oxidation state in protein structure and function.Angew. Chem. Int. Ed. Engl.42(39), 4742–4758 (2003).
   PubMed Web of Science ®Google Scholar
• Arnér ES . Selenoproteins – what unique properties can arise with selenocysteine in place of cysteine?Exp. Cell Res.316, 1296–1303 (2010).
   PubMed Web of Science ®Google Scholar
• Fahey JW , ZalcmannAT, TalalayP. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants.Phytochemistry56(1), 5–51 (2001).
   PubMed Web of Science ®Google Scholar
• Drewnowski A , Gomez-CarnerosC. Bitter taste, phytonutrients, and the consumer: a review.Am. J. Clin. Nutr.72(6), 1424–1435 (2000).
   PubMed Web of Science ®Google Scholar
• Cinciripini PM , HechtSS, HenningfieldJE, ManleyMW, KramerBS. Tobacco addiction: implications for treatment and cancer prevention.J. Natl Cancer Inst.89(24), 1852–1867 (1997).
   PubMedGoogle Scholar
• Fenwick GR , HeaneyRK, MullinWJ. Glucosinolates and their breakdown products in food and food plants.Crit. Rev. Food Sci. Nutr.18(2), 123–201 (1983).
   PubMed Web of Science ®Google Scholar
• Zhang Y , TalalayP. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms.Cancer Res.54(7 Suppl.), 1976s–1981s (1994).
   PubMed Web of Science ®Google Scholar
• Maheo K , MorelF, LangouetSet al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57(17), 3649–3652 (1997).
   PubMed Web of Science ®Google Scholar
• Chen YR , WangW, KongAN, TanTH. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates.J. Biol. Chem.273(3), 1769–1775 (1998).
   PubMed Web of Science ®Google Scholar
• Yu R , MandlekarS, HarveyKJ, UckerDS, KongAN. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity.Cancer Res.58(3), 402–408 (1998).
   PubMed Web of Science ®Google Scholar
• Kassahun K , DavisM, HuP, MartinB, BaillieT. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates.Chem. Res. Toxicol.10(11), 1228–1233 (1997).
   PubMed Web of Science ®Google Scholar
• Conaway CC , GetahunSM, LiebesLLet al. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 38(2), 168–178 (2000).
   PubMed Web of Science ®Google Scholar
• Chung FL , ConawayCC, RaoCV, ReddyBS. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate.Carcinogenesis21(12), 2287–2291 (2000).
   PubMed Web of Science ®Google Scholar
• Chung FL , JiaoD, ConawayCC, SmithTJ, YangCS, YuMC. Chemopreventive potential of thiol conjugates of isothiocyanates for lung cancer and a urinary biomarker of dietary isothiocyanates.J. Cell. Biochem. Suppl.27, 76–85 (1997).
   PubMedGoogle Scholar
• Beecher CW . Cancer preventive properties of varieties of Brassica oleracea: a review.Am. J. Clin. Nutr.59(5 Suppl.), 1166S–1170S (1994).
   PubMed Web of Science ®Google Scholar
• Talalay P , FaheyJW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism.J. Nutr.131(11 Suppl.), 3027S–3033S (2001).
   PubMed Web of Science ®Google Scholar
• Ip C , GantherHE. Comparison of selenium and sulfur analogs in cancer prevention.Carcinogenesis13, 1167–1170 (1992).
   PubMed Web of Science ®Google Scholar
• Clark LC , CombsGF Jr, Turnbull BW et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. nutritional prevention of cancer study group. JAMA276(24), 1957–1963 (1996).
   PubMed Web of Science ®Google Scholar
• Combs GF Jr, Lu J. Selenium as a Cancer Preventive Agent. Kluwer Academic Publishers, Dordrecht, The Netherlands, 205–218 (2001).
   Google Scholar
• Combs GJ Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol. Ther.79(3), 179–192 (1998).
   PubMed Web of Science ®Google Scholar
• Lipinski CA , LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv. Drug Del. Rev.23, 3–25 (1997).
   Web of Science ®Google Scholar
• Crampsie MA , JonesN, DasAet al. Phenylbutyl isoselenocyanate modulates Phase I and II enzymes and inhibits 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone-induced DNA adducts in mice. Cancer Prev. Res. (Phila.) 4(11), 1884–1894 (2011).
   PubMed Web of Science ®Google Scholar
• Stahl JM , CheungM, SharmaA, TrivediNR, ShanmugamS, RobertsonGP. Loss of PTEN promotes tumor development in malignant melanoma.Cancer Res.63(11), 2881–2890 (2003).
   PubMed Web of Science ®Google Scholar
• Stahl JM , SharmaA, CheungMet al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res. 64(19), 7002–7010 (2004).
   PubMed Web of Science ®Google Scholar
• Crampsie MA , PandeyMK, DesaiD, SpallholzJ, AminS, SharmaAK. Phenylalkyl isoselenocyanates vs phenylalkyl isothiocyanates: thiol reactivity and its implications.Chem. Biol. Interact.200(1), 28–37 (2012).
   PubMed Web of Science ®Google Scholar
• Krishnegowda G , Prakasha GowdaAS, TagaramHRet al. Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway. Bioorg. Med. Chem.19(20), 6006–6014 (2011).
   PubMed Web of Science ®Google Scholar
• Vine KL , LockeJM, RansonM, BenkendorffK, PyneSG, BremnerJB. In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg. Med. Chem.15(2), 931–938 (2007).
   PubMed Web of Science ®Google Scholar
• Chung CY , MadhunapantulaSV, DesaiD, AminS, RobertsonGP. Melanoma prevention using topical PBISe.Cancer Prev. Res. (Phila.)4(6), 935–948 (2011).
   PubMed Web of Science ®Google Scholar
• Desai D , SalliU, VranaKE, AminS. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors.Bioorg. Med. Chem. Lett.20(6), 2044–2047 (2010).
   PubMed Web of Science ®Google Scholar
• Karelia N , DesaiD, HengstJA, AminS, RudrabhatlaSV, YunJ. Selenium-containing analogs of SAHA induce cytotoxicity in lung cancer cells.Bioorg. Med. Chem. Lett.20(22), 6816–6819 (2010).
   PubMed Web of Science ®Google Scholar
• Gowda R , MadhunapantulaSV, DesaiD, AminS, RobertsonGP. Selenium-containing histone deacetylase inhibitors for melanoma management.Cancer Biol. Ther.13(9) (2012).
   PubMed Web of Science ®Google Scholar
• Desai D , KaushalN, GandhiUHet al. Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. Chem. Biol. Interact. 188(3), 446–456 (2010).
   PubMed Web of Science ®Google Scholar
• Desai D , SinhaI, NullKet al. Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells. Int. J. Cancer 127(1), 230–238 (2010).
   PubMed Web of Science ®Google Scholar

Website

• US Department of Agriculture, Agricultural Research Service National Nutrient Database for Standard Reference, Release 24. Nutrient Data Laboratory Home Page. www.ars.usda.gov/ba/bhnrc/ndl
   Google Scholar